缓解勒沃多巴的肠道微生物降解和增强大脑多巴胺:对帕金森病的影响
Gang Cheng1, Micael Hardy2, Cecilia J Hillard3
1Department of Biophysics, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, 53226, USA.
Communications biology
|May 30, 2024
概括
一种新型化合物,Mito-ortho-HNK,降低了肠道细菌在帕金森病中对levodopa的代谢. 这种方法增强了莱沃多巴在大脑中的生物可用性和有效性.
科学领域:
- 神经科学是一个神经科学.
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 帕金森病的治疗依赖于利沃多巴,但随着疾病的进展,疗效会下降.
- 增加的勒沃多巴剂量会导致副作用,其口服生物利用性会因肠道细菌代谢而降低.
- 在肠道中存在的Enterococcus faecalis将利沃多巴转化为多巴胺,限制了它对大脑的可用性.
研究的目的:
- 调查米托-奥托-HNK作为一种治疗策略,以提高勒沃多巴的生物可用性.
- 为了确定Mito-ortho-HNK是否可以减轻肠道细菌对levodopa的代谢.
主要方法:
- 合成了由Honokiol和一个Triphenylphosphonium部分衍生出的Mito-ortho-HNK.
- 评估了Mito-ortho-HNK对Enterococcus faecalis对莱沃多巴代谢的影响.
- 在存在Mito-ortho-HNK时,测量了肠道和大脑多巴胺水平的变化.
主要成果:
- 米托-奥托-HNK抑制了Enterococcus faecalis的生长.
- 该化合物降低了肠道中的多巴胺水平.
- mito-ortho-HNK 治疗导致大脑中多巴胺水平增加.
结论:
- 米托-奥托-HNK有效地减轻了肠道细菌对莱沃多巴的代谢.
- 这一策略显示了提高莱沃多巴在帕金森病治疗疗效的潜力.
- 准肠道细菌代谢是帕金森病管理的一个有希望的方法.
相关概念视频
01:24Parkinson's Disease: Treatment
257
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
257
01:15Parkinson's Disease: Overview
527
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
527
01:29Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
01:37Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
307
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
307
01:28Drug Therapy
42
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
42